NCT00463515View on ClinicalTrials.gov

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Non-Small-Cell-Lung Cancer
Interventions
DRUG

carboplatin/gemcitabine

PROCEDURE

cisplatin/radiation therapy

Trial Locations (3)

Unknown

ZNA Middelheim, Antwerp

University Hospital Antwerp, Edegem

Sint Augustinus Ziekenhuis, Wilrijk

All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

collaborator

Eli Lilly and Company

INDUSTRY

lead

University Hospital, Antwerp

OTHER

NCT00463515 - Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC | Biotech Hunter | Biotech Hunter